Navigation Links
Green & Grow Inc. Secures $6M Series B Funding from Otter Capital
Date:8/27/2014

Austin, TX (PRWEB) August 27, 2014

Green & Grow Inc. (GGI) has raised an additional $6 million in Series B funding and secured Otter Capital as a significant new partner. Otter Capital’s expertise and investment capital will accelerate commercialization of GGI’s Agriplier™ technology, building on recent compelling field trial results across multiple crop types.

“Since our first meeting, we have been impressed with Otter Capital’s knowledge and commitment to the biological product space,” said Alan Sobba, President and CEO of GGI. “We look forward to John’s valuable input and guidance as we work together to complete the commercialization of our exciting technology.”

GGI’s range of Agriplier™ products is based on non-living, non-toxic, microbe derived by-products which contain specific metabolites and stimulants that significantly improve many crops. In the 2013 Independent Professional Seed Association (IPSA) trials, GGI products were the top performing yield enhancement seed treatment products across both corn and soybean, increasing yield over the current commercial seed treatment package. Independent researchers also observe visual improvements in early season plant vigor. Similar results have been demonstrated across a wide range of crops and geographies. The compatibility of Agriplier™ products with both existing chemical and living biological products is also a key differentiator, which will simplify the adoption of the technology.

“I am excited by the potential for selected biologically derived products to make a significant impact in the agriculture industry and the 2013 Green & Grow field trial results illustrate that its technology has already made the critical leap from the lab to achieving success in the field,” said John Pasquesi, Managing Member of Otter Capital and former Chairman of the Board of AgraQuest. “I look forward to working with the GGI team to optimize the delivery of their technology to market and to continue to build the business.”

GGI is currently mid-way through the process of working with industry partners, distributors and end-users to bring the Agriplier™ technology to market. Otter Capital’s investment and experience with this process will significantly assist GGI in selecting the most appropriate route to market and in completing this process.

GGI was represented by Sidley Austin LLP in the transaction, and Otter Capital was represented by Greene Radovsky Maloney Share & Hennigh LLP.

About Otter Capital

Otter Capital has a strong track record developing leading edge agriculture and food production companies. Otter was an early and consistent investor in AgraQuest, a leading biopesticide company. In 2012, Bayer CropScience acquired AgraQuest for $425 million plus earnouts. John Pasquesi previously served as Chairman of the Board of Directors of AgraQuest. More recently, Otter Capital invested alongside Khosla Ventures in a $15 million funding round for BioConsortia, Inc. - an agricultural biotechnology company.

Otter Capital was founded by John Pasquesi to make a variety of private equity investments. Prior to founding Otter Capital in 2001, he was a Managing Director and member of the Executive Committee of Hellman & Friedman LLC - a private equity investment firm. Prior to joining Hellman & Friedman in 1987, Pasquesi was associated with Golder, Thoma & Cressey - a Chicago-based private equity firm.

For more information on Otter Capital, please visit http://www.ottercapital.com.

About Green & Grow Inc.

Green & Grow Inc. (GGI) is dedicated to developing and commercializing biologically derived agricultural products.

Its first range of Agriplier™ products is based on non-living, non-toxic, microbe derived by-products which contain specific metabolites and stimulants that significantly improve many crops.

Agriplier™ products can be easily integrated into multiple seed treatment processes, as well as utilized as a soil amendment. As a non-living product, a key differentiator of Agriplier™ is that it can be easily integrated as an additive solution to both existing chemical and living biological products.

GGI has recently developed a line of OMRI listed products which utilize the Agriplier™ technology. These are being rolled out for ongoing trials with a small number of early adopters.

For more information about GGI and its technologies, please visit http://www.greenandgrow.com.

Agriplier™ is a registered trademark of Green & Grow Inc., a Delaware corporation.

###

Read the full story at http://www.prweb.com/releases/greenandgrow/agriplier/prweb12124330.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Infinity Group Invests US$4.2 M in Green BioTech Company BotanoCap
2. Green Dot Develops Compostable Synthetic Leather Made with its Terratek® Flex Bioplastic
3. A New Kind of Medical Thriller in Susy Gage's "Not Easy Being Green," Coming 2015 from Bitingduck Press
4. Cargill’s Dielectric Transformer Oil Made from Natural Esters Wins Presidential Green Chemistry Award
5. Topical BioMedics' Topricin Foot Therapy Cream for Diabetics Now Available in Walgreens' Diabetic Section
6. CareMetx, LLC Combines Operations with Walgreens-Owned Pharma Dynamics, Inc.
7. Green Dot Introduces New Terratek® WC Wood-Plastic Composite Pellets Optimized for Injection Molding and Sheet Extrusion
8. M&G Chemicals Launches Green Revolution in the Polyester Chain
9. Focus on Green Growth and Environmental Sustainability Drives the Global Market for Marine Biotechnology, According to New Report by Global Industry Analysts, Inc.
10. Robert Greenough’s New Book Examines Quantum Reality
11. Shocking News & Research: Boston Scientific, Yingli Green Energy Hold, QUALCOMM, PulteGroup, Regions Financial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 ... Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published ... the peer-reviewed journal from touchONCOLOGY, Andrew D ... cost of cancer care is placing an increasing ... of expensive biologic therapies. With the patents on ...
(Date:6/23/2016)... ... 2016 , ... Velocity Products, a division of Morris Group, ... exclusively for Okuma CNC machining centers at The International Manufacturing Technology Show, IMTS, ... companies with expertise in toolholding, cutting tools, machining dynamics and distribution, Velocity SMART ...
(Date:6/22/2016)... Research and Markets has announced the addition ... their offering. The global ... billion in 2013. The market is expected to grow at a ... 2020, increasing from $50.6 billion in 2015 to $96.6 billion in ... forecast period (2015 to 2020) are discussed. As well, new products ...
(Date:6/22/2016)...   ViaCyte, Inc. , a privately-held regenerative medicine ... therapy for the treatment of diabetes in clinical-stage development, ... ISSCR 2016, the Global Stem Cell Event, is taking ... San Francisco.    ... , Focus Session: Tools for Basic and Applied Stem ...
Breaking Biology Technology:
(Date:6/15/2016)... 15, 2016 Transparency Market ... Recognition Market by Application Market - Global Industry Analysis Size ... to the report, the  global gesture recognition market ... and is estimated to grow at a CAGR ... 2024.  Increasing application of gesture recognition ...
(Date:6/3/2016)... , June 3, 2016 ... Management) von Nepal ... und Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, ... führend in der Produktion und Implementierung von ... der Ausschreibung im Januar teilgenommen, aber Decatur ...
(Date:6/1/2016)... 1, 2016 Favorable Government Initiatives ... and Criminal Identification to Boost Global Biometrics System Market ... TechSci Research report, " Global Biometrics Market By ... and Opportunities, 2011 - 2021", the global biometrics market ... on account of growing security concerns across various end ...
Breaking Biology News(10 mins):